Searched over 200M research papers
10 papers analyzed
These studies suggest metformin causes diarrhea due to factors like reduced Na+ and water absorption, inhibition of NHE3 by AMPK, and changes in gut microbiota, with symptoms often resolving after discontinuation of the drug.
20 papers analyzed
Metformin is a widely prescribed medication for managing type 2 diabetes mellitus. Despite its effectiveness, it is notorious for causing gastrointestinal side effects, particularly diarrhea. This article explores the various mechanisms proposed by research to explain why metformin induces diarrhea.
Diarrhea is a common side effect of metformin, affecting approximately 30% of patients. Studies have shown that metformin-treated diabetic patients have a significantly higher prevalence of diarrhea compared to those not on the drug. This adverse effect can be severe enough to cause discontinuation of the medication in some cases.
One of the primary mechanisms proposed involves the inhibition of the Na+/H+ exchanger 3 (NHE3) in the intestine. NHE3 is crucial for sodium absorption, and its inhibition by metformin leads to decreased water absorption, resulting in diarrhea. This effect is mediated through the activation of 5′-AMP-activated protein kinase (AMPK), which increases the phosphorylation and ubiquitination of NHE3, causing its removal from the plasma membrane.
Metformin has been shown to affect the digestive uptake of bile salts, which can lead to malabsorption and diarrhea. Increased bile flow and the upregulation of cystic fibrosis transmembrane conductance regulator (CFTR) in the ileum and colon have also been implicated. CFTR is a key ion channel involved in chloride and water secretion, and its increased expression can contribute to diarrhea.
Metformin can alter the gut microbiota, which may disturb the balance of intestinal flora and lead to gastrointestinal side effects. It has been suggested that metformin decreases the production of folate and methionine by gut bacteria, which could contribute to diarrhea. The reduction in certain groups of enterobacteria, such as Firmicutes, has also been associated with metformin-induced diarrhea.
Another hypothesis involves the stimulation of intestinal serotonin secretion and changes in incretin and glucose metabolism, which can affect gut motility and lead to diarrhea. However, these mechanisms are not yet fully understood and require further research.
Given the high prevalence and potential severity of metformin-induced diarrhea, it is crucial for clinicians to recognize this side effect. Discontinuation of metformin often resolves the symptoms within a few days . In some cases, switching to an extended-release formulation of metformin may reduce the incidence of gastrointestinal side effects.
Metformin-induced diarrhea is a multifaceted issue involving altered intestinal transport, bile salt malabsorption, changes in gut microbiota, and possibly serotonin and incretin changes. Understanding these mechanisms can help in managing this common side effect and improving the quality of life for patients on metformin therapy.
Most relevant research papers on this topic